Literature DB >> 68659

Tumor-bound immunoglobulins: in situ expressions of humoral immunity.

I P Witz.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 68659

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  9 in total

Review 1.  Membrane antigens associated with infection, transformation, and tumorigenesis by polyoma virus.

Authors:  I P Witz; G Meyer
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  Selective killing of Fc-receptor-bearing tumor cells through endocytosis of a drug-carrying immune complex.

Authors:  W C Shen; H J Ryser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

3.  Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.

Authors:  T Tanaka; H Yamagishi; N R Pellis; B D Kahan
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Tumour cell-antibody interactions. II. In vitro studies.

Authors:  G Froese; I Berczi; L G Israels
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

5.  Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular salivary glands.

Authors:  F R Korsrud; P Brandtzaeg
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

Review 6.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

7.  Detection of circulating antibodies against c-myc protein in cancer patient sera.

Authors:  K Ben-Mahrez; D Thierry; I Sorokine; A Danna-Muller; M Kohiyama
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

8.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23

9.  Association of host immunoglobulins with solid tumours in vivo.

Authors:  K James; Y H Bessos; J Merriman
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.